bluebird bio Inc. (NASDAQ: BLUE)
$1.31
-0.0100 ( -0.76% ) 1.9M
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$1.31
Previous close
$1.32
Volume
1.9M
Market cap
$182.68M
Day range
$1.31 - $1.36
52 week range
$0.85 - $5.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Mar 05, 2024 |
4 | Insider transactions | 2 | Feb 06, 2024 |
4 | Insider transactions | 2 | Feb 06, 2024 |
4 | Insider transactions | 2 | Feb 06, 2024 |
4 | Insider transactions | 2 | Jan 09, 2024 |
4 | Insider transactions | 2 | Jan 09, 2024 |
8-k | 8K-related | 37 | Jan 08, 2024 |
8-k | 8K-related | 12 | Jan 04, 2024 |
8-k | 8K-related | 16 | Dec 20, 2023 |
8-k | 8K-related | 15 | Dec 18, 2023 |